封面
市場調查報告書
商品編碼
1664002

特種酵素市場規模、佔有率和成長分析(按來源、產品類型、應用和地區)- 產業預測 2025-2032

Specialty Enzymes Market Size, Share, and Growth Analysis, By Source (Plants, Animals), By Product Type (Carbohydrases, Proteases), By Application, By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 189 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計 2023 年全球特種酵素市場規模將達到 61.6 億美元,並從 2024 年的 66.1 億美元成長到 2032 年的 116.1 億美元,預測期內(2025-2032 年)的複合年成長率為 7.3%。

受製藥業需求不斷成長的推動,特種酶市場預計將經歷強勁成長。酵素在促進藥物發現、開發和生產過程中發揮著至關重要的作用。從先導化合物最佳化到治療目標檢驗,酵素在藥物開發的許多階段都至關重要。透過促進生化途徑的研究,酵素可幫助研究人員確定潛在的治療目標並評估新藥物的功效。在藥物中間體和類似物的合成中使用酵素簡化了開發平臺。此外,特種酵素在生技藥品和活性藥物成分 (API) 的製造中至關重要,它可作為生物催化劑來提高效率和選擇性、降低成本、提高產量並減少環境影響,從而極大地影響藥物配方。

目錄

介紹

  • 調查目的
  • 研究範圍
  • 定義

調查方法

  • 資訊採購
  • 次要和主要資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分機會分析

市場動態及展望

  • 市場概況
  • 市場規模
  • 市場動態
    • 促進因素和機會
    • 限制與挑戰
  • 波特的分析

主要市場考察

  • 關鍵成功因素
  • 競爭程度
  • 主要投資機會
  • 市場生態系統
  • 市場吸引力指數(2024 年)
  • PESTEL 分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析
  • 案例研究
  • 專利分析

特種酵素市場規模(按來源和複合年成長率) (2025-2032)

  • 市場概況
  • 植物
  • 動物
  • 微生物

特種酵素市場規模(按產品類型和複合年成長率) (2025-2032)

  • 市場概況
  • 碳水化合物分解酶
  • 蛋白酶
  • 脂肪酶
  • 聚合酵素和核酸酶
  • 其他

特種酵素市場規模(依應用分類)及複合年成長率(2025-2032)

  • 市場概況
  • 食品和飲料
  • 藥品
  • 動物營養
  • 生物技術
  • 診斷
  • 其他

特種酵素市場規模(依地區分類)及複合年成長率(2025-2032)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲國家
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前 5 家公司對比
  • 主要企業市場定位(2024年)
  • 主要市場參與者所採用的策略
  • 近期市場趨勢
  • 公司市場佔有率分析(2024 年)
  • 主要企業簡介
    • 公司詳細資訊
    • 產品系列分析
    • 公司分部佔有率分析
    • 收益與前一年同期比較對比(2022-2024 年)

主要企業簡介

  • Novozymes A/S(Denmark)
  • DuPont de Nemours, Inc.(USA)
  • DSM(Netherlands)
  • BASF SE(Germany)
  • Advanced Enzyme Technologies Ltd.(India)
  • Amano Enzyme Inc.(Japan)
  • Codexis, Inc.(USA)
  • Sanofi(France)
  • Roche Holding AG(Switzerland)
  • Thermo Fisher Scientific Inc.(USA)
  • Biocatalysts Ltd.(UK)
  • Merck KGaA(Germany)
  • Kerry Group plc(Ireland)
  • Specialty Enzymes & Probiotics(USA)
  • AST Enzymes(USA)
  • Nagase & Co., Ltd.(Japan)
  • Dyadic International, Inc.(USA)
  • AB Enzymes GmbH(Germany)
  • Enzyme Development Corporation(USA)

結論和建議

簡介目錄
Product Code: SQMIG35H2329

Global Specialty Enzymes Market size was valued at USD 6.16 billion in 2023 and is poised to grow from USD 6.61 billion in 2024 to USD 11.61 billion by 2032, growing at a CAGR of 7.3% during the forecast period (2025-2032).

The specialty enzymes market is poised for robust growth, driven by the increasing demand from the pharmaceutical sector. Enzymes play a pivotal role in enhancing drug discovery, development, and production processes. They are integral to various phases of drug development, from optimizing lead compounds to validating therapeutic targets. By facilitating the study of biochemical pathways, enzymes help researchers identify potential therapeutic targets and evaluate the effectiveness of new substances. Their use in synthesizing drug intermediates and analogues streamlines the development pipeline. Moreover, specialty enzymes are crucial in the manufacturing of biologics and active pharmaceutical ingredients (APIs), acting as biocatalysts that enhance efficiency and selectivity, reduce costs, improve yields, and lower environmental impact, significantly influencing pharmaceutical formulations.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Specialty Enzymes market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Specialty Enzymes Market Segments Analysis

Global Specialty Enzymes Market is segmented by Source, Product Type, Application and region. Based on Source, the market is segmented into Plants, Animals and Microorganisms. Based on Product Type, the market is segmented into Carbohydrases, Proteases, Lipases, Polymerases & Nucleases and Others. Based on Application, the market is segmented into Food & Beverages, Pharmaceuticals, Animal Nutrition, Biotechnology, Diagnostics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Specialty Enzymes Market

The increasing global emphasis on sustainability is a significant driver of growth in the specialty enzymes market. As both consumers and businesses prioritize eco-friendly and biodegradable options, sectors like food, textiles, and cleaning are experiencing heightened demand. This shift toward cleaner and more sustainable solutions propels the adoption of enzymes in various applications. Companies are actively seeking innovative, environmentally conscious alternatives, which further amplifies the market's expansion. The integration of specialty enzymes in these industries not only meets consumer expectations for sustainability but also aligns with broader environmental goals, ultimately fostering increased market activity and development in this sector.

Restraints in the Global Specialty Enzymes Market

Limited awareness of the advantages and versatile applications of specialty enzymes in certain regions and industries serves as a significant constraint on the Global Specialty Enzymes market. A considerable number of companies continue to rely on conventional chemical processes, making the transition to enzyme-based solutions challenging. This shift necessitates substantial education and investment, causing slower adoption rates, particularly in emerging markets. Consequently, the lack of understanding and readiness to embrace innovative enzyme technologies hampers market growth and stifles the potential benefits that these advanced solutions could offer to various sectors. Thus, this lack of awareness remains a considerable barrier.

Market Trends of the Global Specialty Enzymes Market

The Global Specialty Enzymes market is witnessing a significant trend towards the adoption of eco-friendly and biodegradable enzyme solutions, driven by increasing environmental awareness among consumers and businesses alike. Industries such as food and beverage, textiles, and cleaning are prioritizing sustainability, opting for specialty enzymes that minimize ecological footprints. This shift not only caters to consumer demand for greener products but also aligns with regulatory pressures for reduced environmental impact. Consequently, manufacturers are focusing on innovation and the development of cleaner, more efficient enzymatic processes, positioning themselves strategically to meet the rising emphasis on sustainability, thereby fueling market growth.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Patent Analysis

Global Specialty Enzymes Market Size by Source & CAGR (2025-2032)

  • Market Overview
  • Plants
  • Animals
  • Microorganisms

Global Specialty Enzymes Market Size by Product Type & CAGR (2025-2032)

  • Market Overview
  • Carbohydrases
  • Proteases
  • Lipases
  • Polymerases & Nucleases
  • Others

Global Specialty Enzymes Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Food & Beverages
  • Pharmaceuticals
  • Animal Nutrition
  • Biotechnology
  • Diagnostics
  • Others

Global Specialty Enzymes Market Size & CAGR (2025-2032)

  • North America (Source, Product Type, Application)
    • US
    • Canada
  • Europe (Source, Product Type, Application)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Source, Product Type, Application)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Source, Product Type, Application)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Source, Product Type, Application)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Novozymes A/S (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DuPont de Nemours, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DSM (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BASF SE (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Advanced Enzyme Technologies Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Amano Enzyme Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Codexis, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanofi (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Holding AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biocatalysts Ltd. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kerry Group plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Specialty Enzymes & Probiotics (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AST Enzymes (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nagase & Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dyadic International, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AB Enzymes GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Enzyme Development Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations